Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Clinical stage, novel technologies for managing Glaucoma
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Cantai Therapeutics operates as a developer of drug candidates.
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.
Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.
Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 27 different industry categories.
Among tracked funding rounds, Mosanna Therapeutics received $80.0M in a Series A round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include Smartlens, AeroRx Therapeutics, OncoC4, Nionyx Bio, ARTHEx Biotech. These companies were founded in 2020 or later.